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INTRODUCTION
Comorbid psychiatric disorders have been attracting
attention, since they may exert significant influence
on what is presumed to be the major or underlying
psychiatric disorder (1-3). Anxiety symptoms, as
well as depressive symptoms, are not uncommon in
psychiatric disorders. Moreover, anxiety and depres-
sive symptoms commonly co-occur (1), though the
underlying mechanisms for this covariation remain
poorly understood. In previous reports, measures
assessing anxiety and depressive levels showed
strong correlations between them in a nonclinical
sample (4), and a clinical sample (5). However, in
these studies, depression and anxiety were not
clearly differentiated. The aim of this study is to
investigate the level of anxiety and depressive
symptoms and the associations between them in
normal subjects and patients with mood and/or
anxiety disorders, using the Japanese version (6) of
Spielberger’s State-Trait Anxiety Inventory (STAI) (7)
and the Zung Self-Rating Depression Scale (SDS) (8).
METHODS
The subjects for the present study were 60 nor-
mal subjects (35 females and 25 males), 15 patients
(6 females and 9 males) with anxiety disorders and,
12 patients (11 females and a male) with mood dis-
orders meeting the DSM (Diagnostic and Statistical
Manual of the American Psychiatric Association)-IV
(9) diagnostic criteria (Appendix 1). None of the
patients with anxiety disorders meets the current defi-
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nitional threshold for DSM-IV axis I mood disorders,
and none of the patients with mood disorders meets
that for anxiety disorders. Informed consent was
obtained from all subjects for the research involved
in this study. Normal subjects and patients with
anxiety or mood disorders had respective ages of
40.3±10.3 years, 42.0±14.3 years and 45.3±16.8
years (Table 1).
Psychiatric ratings were done using the Japanese
version (6) of the STAI (7) and the Japanese version
(10) of the SDS (8). The STAI is composed of two
separate 20-item scales constructed to measure
“state”and“trait”anxiety, using 4-point scales. On the
State Scale, the respondent is asked to indicate“how
[he/she] feels right now, that is, at this moment”
with respect to each of 20 different items. On the
Trait Scale, the respondent is asked to indicate
“how [he/she] generally feels”with respect to each
of 20 different items. Scores correlate with expected
results under stressful and nonstressful experimen-
tal conditions and discriminated neuropsychiatric
patients from community residents. The STAI
scores were calculated for the complete 40-item
measure. The SDS is composed of 20-item scales
constructed to measure depressive symptoms, using
4-point scales. The SDS was devised to quantitate
the symptoms of depression, and scores correlate
with clinical evaluation of patients for the presence
of depressive disorders. The SDS scores were cal-
culated for the complete 20-item measure.
Statistical analyses were done using nonparam-
etric tests (Mann Whitney’s U-test, Spearman’s
rank correlation) because of small samples.
RESULTS
1. Anxiety
In normal subjects, patients with anxiety disorders
and patients with mood disorders, total state-anxiety
(S-anxiety) scores were 41.6±8.6, 51.0±11.6 and
53.8±12.5, respectively, while, total trait-anxiety
(T-anxiety) scores were 42.5±8.7, 52.9±15.1 and
58.7±11.3 (Table 1). Both the mean total S-anxiety
and T-anxiety scores were significantly higher in
patients with anxiety disorders and mood disorders
than in normal subjects (U-test, p<.01), while there
was no significant difference between patient
groups.
2. Depressive symptoms
In normal subjects, patients with anxiety disorders
Table 1. Demographic characteristics of subjects
N
Age (yr)
Mean±SD
Total state-anxiety scores
Mean±SD
Total trait-anxiety scores
Mean± SD
Total SDS scores
Mean±SD
Normals 60 40.3±10.3 41.6± 8.6 42.5± 8.7 34.4± 9.3
Anxiety disorders 15 42.0±14.3 51.0±11.6** 52.9±15.1** 48.3±13.5**
Mood disorders 12 45.3±16.8 53.8±12.5** 58.7±11.3** 48.9± 9.2**
SDS = the Zung Self-Rating Depression Scale.
**p<.01 versus normals by Mann Whitney’s U-test.
Table 2. Correlations between depressive and anxiety symptoms
ρ－ p values
Normals State-anxiety .362 p<.05
Trait-anxiety .621 p<.01
Anxiety disorders State-anxiety .611 p<.05
Trait-anxiety .775 p<.01
Mood disorders State-anxiety .413 NS
Trait-anxiety .529 NS
ρ－＝coefficients by Spearman rank correlations．
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and mood disorders, total SDS scores were 34.4±
9.3, 48.3±13.5 and 48.9±9.2, respectively (Table 1).
The mean total SDS score was significantly higher
in patients with anxiety disorders and mood dis-
orders than normal subjects (U-test, p<.01), while
there was no significant difference between the
patient groups.
3. Relationship between anxiety and depressive
symptoms
3-1. Relationship between anxiety and depressive
symptoms in normal subjects
The relations between anxiety and depressive
symptoms in normal subjects are shown in Table 2.
In normal subjects, there were positive correlations
between the total T- and S-anxiety scores and total
SDS scores (T-anxiety and SDS : Spearman’s ρ=.621,
p<.01, N=60 ; T-anxiety and S-anxiety : ρ=.727, p<.01,
S-anxiety and SDS : ρ=.362, p<.05).
3-2. Relationship between anxiety and depressive
symptoms in patients with anxiety disorders
Table 2 shows the relationship between the total
T- and S-anxiety scores and total SDS scores in
patients with anxiety disorders. In patients with
anxiety disorders, there were positive correlations
between the total T- and S-anxiety scores and total
SDS scores (T-anxiety and SDS : Spearman’s ρ=.775,
p<.01, N=15 ; T-anxiety and S-anxiety : ρ=.696, p<.01,
S-anxiety and SDS : ρ=.611, p<.05).
3-3. Relationship between anxiety and depressive
symptoms in patients with mood disorders
Table 2 also shows the relationship between the
total T- and S-anxiety scores and total SDS scores
in patients with mood disorders. In patients with
mood disorders, there were positive correlations
between the total T- and S-anxiety scores and total
SDS scores (T-anxiety and SDS : Spearman’s ρ=.529,
NS, N=12 ; T-anxiety and S-anxiety : ρ=.839, p<.01,
S-anxiety and SDS : ρ=.413, NS).
DISCUSSION
In the present study, there were significant positive
correlations between the total T- and S-anxiety
scores and total SDS scores in normal subjects and
patients with anxiety disorders, and in patients with
mood disorders, the total T- and S-anxiety scores
were nonsignificantly and positively correlated with
the total SDS scores. The results of our findings
are consistent with the previous reports of Dobson
(4) and Mendels et al. (5). Moreover, the SDS
scores were more clearly associated with T-anxiety
versus S-anxiety scores. These findings are sur-
prising, since anxiety and depression seem to be
phenomenologically distinct experiences. However,
the high correlations between anxiety and depression
provide support for the existence of common under-
lying mechanisms, although further research with
more samples is required. Meanwhile, our findings
may explain the difficulty of differentiating anxiety
and depression in clinical practice (11).
So far, the therapeutic success of conventional
antidepressants [e.g., tricyclic antidepressants (12)]
and newer antidepressants [e.g., selective serotonin
(5-HT) reuptake inhibitor (13)] in anxiety disorders
has suggested the existence of common underlying
mechanisms to anxiety and depression. Anxiety
(14) and depression (15) involve a dysregulation
in the function of several transmitters including
5-HT and noradrenaline. And, the evidence from
pharmacological studies that 5-HTergic medications
are effective in alleviating both anxiety and depression
is indicative of 5-HTergic dysregulation as a common
mechanism underlying anxiety and depression.
Further, investigations conducted with child and
adolescent samples (16) suggest that anxiety sensi-
tivity is positively related to depression. In addition,
the results of Thapar, et al. (17) suggest that most
of the covariation of maternally rated anxiety and
depressive symptoms can be explained by a common
set of genes that influence anxiety and depressive
symptoms.
It is not yet clear what determines the difference
between anxiety and depressive symptoms. However,
in treating depression, 5-HTergic medications are
as effective as noradrenergic drugs, and in anxiety,
both 5-HTergic and noradrenergic drugs are effec-
tive although the 5-HTergic medication is somewhat
more potent (18). Therefore, these different re-
sponses may highlight the differences between
anxiety and depression.
Lastly, we must point out the possibility that the
two self-rating measurements used in this study, the
STAI and SDS, might share common components
as noted by Feldman (19), though Nelson and Novy
have reported that with the STAI and another self-rating
depression scale, the Beck Depression Inventory
(20), it is possible to distinguish different dimen-
sions of anxiety and depression (21). For a clearer
determination of the relation between anxiety and
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depression, we might need more specific tools of
assessment.
CONCLUSIONS
T- and S-anxiety levels are highly correlated with
the level of depression. Our results might provide
support for the existence of t common underlying
mechanisms to anxiety and depression.
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APPENDIX 1.
A. Mood disorders (Major depressive disorder)
Five or more symptoms present for at least two
weeks, with a significant impairment in occupational
or social functioning ; at least (1) or (2) presents.
(1) Abnormal depressed mood (or irritable mood
if a child or adolescent) most of the day,
nearly every day.
(2) Abnormal loss of all interest and pleasure
most of the day, nearly every day.
(3) Appetite or weight disturbance, either : Abnor-
mal weight loss (when not dieting) or weight
gain, or abnormal decrease or increase in
appetite nearly every day.
(4) Sleep disturbance, either abnormal insomnia
or abnormal hypersomnia nearly every day.
(5) Activity disturbance, either abnormal agitation
or abnormal slowing (observable by others)
nearly every day.
(6) Abnormal fatigue or loss of energy nearly
every day.
(7) Abnormal self-reproach or inappropriate guilt
nearly every day.
(8) Abnormal poor concentration or indecisiveness
nearly every day.
(9) Abnormal morbid thoughts of death (not just
fear of dying) or suicide.
B. Anxiety disorders (Generalized anxiety disorder)
Generalized anxiety disorder is excessive anxiety
and worry, occurring most days for more than six
months. It refers to excessive anxiety in a range of
situations that does not fit into any of the more
common syndromes. The anxiety and worry are
associated with three (or more) of the following six
symptoms.
(1) restlessness or feeling keyed up or on edge
(2) being easily fatigued
(3) difficulty concentrating or mind going blank
(4) irritability
(5) muscle tension
(6) sleep disturbance (difficulty falling or staying
asleep, or restless unsatisfying sleep)
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